Rx Label Format Changes Should Be Phased In Without "Highlights" - PhRMA

FDA's prescription drug labeling initiative should proceed in areas where there is consensus between the agency and the pharmaceutical industry, the Pharmaceutical Research & Manufacturers of America said in comments on the proposed rule.